-
Cancer-fighting nano-robots programmed to seek and destroy tumours
europeanpharmaceuticalreview
April 30, 2019
Study shows first applications of DNA origami for nanomedicine…
-
Microbubbles make breast cancer more susceptible to radiation therapy
europeanpharmaceuticalreview
April 29, 2019
Bursting oxygen-filled microbubbles in breast cancer makes tumours three times more sensitive to radiation therapy in preliminary tests with animal models of the disease…
-
NIR identifies breast cancer patients who will benefit from chemotherapy
europeanpharmaceuticalreview
April 29, 2019
Scientists have developed a new optical imaging system that uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy…
-
Lilly to withdraw cancer drug Lartruvo from global market
pharmaceutical-technology
April 28, 2019
Eli Lilly has announced an access programme for patients that wish to continue using its cancer drug Lartruvo (olaratumab) as the company prepares to withdraw the medication from markets worldwide.
-
Ponatinib is found to be effective against SCCOHT
europeanpharmaceuticalreview
April 28, 2019
Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months…
-
Ionising radiation found to soften tumour cell microenvironment
europeanpharmaceuticalreview
April 28, 2019
When irradiated, less stiff extracellular matrices reduced cancer growth and migration, bolstering the case to further understand fractionated radiation therapy…
-
Combination immunotherapy improves survival in mouse models of mesothelioma
europeanpharmaceuticalreview
April 28, 2019
Combined treatment with two cancer immunotherapy drugs significantly prolonged survival in aggressive cancer malignant mesothelioma…
-
Contrast-enhanced subharmonic imaging detects prostate cancers
europeanpharmaceuticalreview
April 25, 2019
A test of contrast-enhanced subharmonic imaging has shown promise in detecting prostate cancers that were not identified by MRI…
-
Delivering cancer treatment on a nanodisc helps eliminate tumours
europeanpharmaceuticalreview
April 25, 2019
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice…
-
Blood test predicts effectiveness of palbociclib in breast cancer patients
europeanpharmaceuticalreview
April 25, 2019
A new study has found a blood test for cancer DNA could predict if a woman is responding to the new breast cancer drug palbociclib, months earlier than current tests…